Shandong Parkson Biotechnology Co., Ltd. was established in 2006 with a registered capital of 200 million yuan and more than 1,000 employees. It is a national high-tech enterprise with the development direction of corn deep processing, biological fermentation and biological manufacturing. Passed the ISO9001 quality management system certification, ISO14001 environmental management system certification, ISO22000 food safety management system, OHSAS18000 occupational health and safety management system, FSSC22000 food safety system certification five system certification. It has won many honorary titles such as "Advanced Energy Saving Enterprise, Top 100 Taxpaying Enterprises in Jining City, Key Leading Enterprise in Agricultural Industrialization in Shandong Province, and Top 100 Enterprises in China's Light Industry".
Since the establishment of the company, the company has consistently implemented the corporate mission of "leading science and technology, helping national defense, optimizing the environment, and caring for people's livelihood", insisting on the "production, learning, research" cooperation road, aiming at the same industry in the world. At the highest level, optimize product structure, extend the biotech industry chain, and actively cultivate and expand strategic emerging industrial projects and high-tech industrial projects.
In recent years, the company has joined forces with Tsinghua University, Jiangnan University, Tianjin University of Science and Technology, Shandong Food Fermentation Industry Research and Design Institute and other universities to break through the technical bottleneck of the bio-manufacturing industry and launched six high-tech industrial projects: glucose Sodium project, glucono-delta-lactone project, lactic acid and lactate project, iso-VC sodium project, polylactic acid project. Our company is one of the largest sodium gluconate production bases in the country, and its gluconate-δ-lactone production capacity ranks first in the world. Our company has mastered a number of core technologies of the world's leading bio-manufacturing industry, and the technology development prospects are broad.
In 2013, the company built a new national standard modern R&D center and pilot test base, equipped with multi-functional microplate reader, continuous protein purification chromatography, gel electrophoresis instrument, ultraviolet imager and other professional R&D equipment. The center focuses on bio-based new Scientific and technological research and development and achievement transformation of materials and organic acid esters. The R&D Center has been recognized as "Shandong Postdoctoral Innovation Practice Base", "Bio-based New Material Engineering Technology Research Center", "Organic Acid ester Engineering Research Center", "Enterprise Technology Center". Through the hard work of the R&D team, it has obtained 35 core intellectual property rights, 3 scientific and technological achievements, 1 provincial-level strategic emerging industry, and 3 provincial-level technological innovation projects; won the "Microbial Industry Innovation Award"; the company won China Bio Member enterprises of national (industry) standard-setting work of the Fermentation Industry Association, participate in the formulation of national standards of related industries, and effectively lead the development of the industry.
In the future, the world will be more open. Parkson Bio will work with partners to build a biotech base with high-end technology, high-end products and high innovation capabilities, to promote the technological progress of the industry and realize the "Chinese Dream" of the great rejuvenation of the Chinese nation. Make new and greater contributions!